Global Antibody Discovery Market

Antibody Discovery Comprehensive Study by Type (Monoclonal Antibodies, Polyclonal Antibodies, Other Antibodies), Application (Healthcare Industry), Nature (Humanized, Human, Chimeric, Murine), Methods (Phage Display, Hybridoma, Transgenic Animal, Yeast Display, Single Cell), End User (Pharmaceutical and Biotechnology Companies, Research Laboratories, Others) Players and Region - Global Market Outlook to 2028

Antibody Discovery Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Antibody Discovery and development is the process of discovering new therapeutic antibodies to combat diseases such as cancer, HIV, autoimmune, hereditary, and others. The technologies used to discover these antibody-based drug candidates have revolutionised science in both industrial and academic labs. The new therapeutic antibody drug enters the clinical phase after the discovery and development process, where it is manufactured for clinical testing and tested in clinical trials. Clinical trials are divided into three phases: Phase 1 tests the drug's safety, Phase II tests the drug's efficacy, and Phase III tests the drug's efficacy and how it compares to current treatment options. A drug candidate is approved for patient distribution after passing all three phases of clinical trials. These ground-breaking antibody therapeutics can be designed in a variety of formats, including full-length antibodies, bispecific antibodies, antibody fragments, and others.This growth is primarily driven by Proteomics and Genomics Research is on the Rise .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitN
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Diseases & Therapeutic Areas sector in the region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Twist Bioscience Corporation (United States), Croda International Plc. (United Kingdom), BASF SE. (Germany), Bruker Corporation (United States), Alcami Corporation, Inc. (United States), BioDuro-Sundia. (China), PharmaCircle LLC. (United States), Frontage Laboratories, Inc. (United States), Eurofins DiscoverX Products, LLC. (French) and Cambrex Corporation (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On 24th March 2022, Ligand Pharmaceuticals was about to spin off its antibody discovery division into a new company when Avista Public Acquisition Corp. came knocking. Ligand announced plans to spin off the unit into a new company focused on producing human antibodies using transgenic animals. The original plan was for OmniAB to go public on its own, but the company ultimately decided on a direct spin-off so that the separation could take place sooner.
On 2nd June 2022, Sanyou Biopharmaceuticals has officially launched STAL, a super-trillion dollar innovative antibody drug discovery platform owned by Sanyou. Sanyou STAL, the result of Sanyou's continuous innovation and independent R & D, represents a significant advancement over the previous generation of sub-trillion innovative antibody discovery platforms. The STAL discovery platform combines nine categories of super-trillion innovative antibody libraries with a total library capacity of up to ten trillion. The screening validations with dozens of targets revealed that the STAL platform can discover thousands of novel lead antibodies, which is dozens or even hundreds of times more than canonical methods.Companies in the antibody library technology market are aiming to form strategic alliances with academic institutions in order to bridge the gap between early scientific discovery and its translation into new medicine. This allows academic research expertise in targets, disease biology, and so on to be combined with industry development and resource expertise.

Influencing Trend:
Increase in the Funding for Research Activities

Market Growth Drivers:
Proteomics and Genomics Research is on the Rise and Expanding Industry-Academia Collaboration

Challenges:
Traditional Molecular Display Technologies Have Drawbacks and Limitations

Restraints:
Difficulties Related To Sample Collection

Opportunities:
Rising Investment in Research & Development Activity with New Product Innovations

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Antibody Discovery Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Antibody Discovery Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Antibody Discovery players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Antibody Discovery Study Sheds Light on
— The Antibody Discovery Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Antibody Discovery industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Antibody Discovery industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • Other Antibodies
By Application
  • Healthcare Industry
By Nature
  • Humanized
  • Human
  • Chimeric
  • Murine

By Methods
  • Phage Display
  • Hybridoma
  • Transgenic Animal
  • Yeast Display
  • Single Cell

By End User
  • Pharmaceutical and Biotechnology Companies
  • Research Laboratories
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Proteomics and Genomics Research is on the Rise
      • 3.2.2. Expanding Industry-Academia Collaboration
    • 3.3. Market Challenges
      • 3.3.1. Traditional Molecular Display Technologies Have Drawbacks and Limitations
    • 3.4. Market Trends
      • 3.4.1. Increase in the Funding for Research Activities
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Antibody Discovery, by Type, Application, Nature, Methods, End User and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Antibody Discovery (Value)
      • 5.2.1. Global Antibody Discovery by: Type (Value)
        • 5.2.1.1. Monoclonal Antibodies
        • 5.2.1.2. Polyclonal Antibodies
        • 5.2.1.3. Other Antibodies
      • 5.2.2. Global Antibody Discovery by: Application (Value)
        • 5.2.2.1. Healthcare Industry
      • 5.2.3. Global Antibody Discovery by: Nature (Value)
        • 5.2.3.1. Humanized
        • 5.2.3.2. Human
        • 5.2.3.3. Chimeric
        • 5.2.3.4. Murine
      • 5.2.4. Global Antibody Discovery by: Methods (Value)
        • 5.2.4.1. Phage Display
        • 5.2.4.2. Hybridoma
        • 5.2.4.3. Transgenic Animal
        • 5.2.4.4. Yeast Display
        • 5.2.4.5. Single Cell
      • 5.2.5. Global Antibody Discovery by: End User (Value)
        • 5.2.5.1. Pharmaceutical and Biotechnology Companies
        • 5.2.5.2. Research Laboratories
        • 5.2.5.3. Others
      • 5.2.6. Global Antibody Discovery Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Australia
          • 5.2.6.2.6. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
  • 6. Antibody Discovery: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Twist Bioscience Corporation (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Croda International Plc. (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. BASF SE. (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bruker Corporation (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Alcami Corporation, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. BioDuro-Sundia. (China)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. PharmaCircle LLC. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Frontage Laboratories, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Eurofins DiscoverX Products, LLC. (French)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Cambrex Corporation (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Antibody Discovery Sale, by Type, Application, Nature, Methods, End User and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Antibody Discovery (Value)
      • 7.2.1. Global Antibody Discovery by: Type (Value)
        • 7.2.1.1. Monoclonal Antibodies
        • 7.2.1.2. Polyclonal Antibodies
        • 7.2.1.3. Other Antibodies
      • 7.2.2. Global Antibody Discovery by: Application (Value)
        • 7.2.2.1. Healthcare Industry
      • 7.2.3. Global Antibody Discovery by: Nature (Value)
        • 7.2.3.1. Humanized
        • 7.2.3.2. Human
        • 7.2.3.3. Chimeric
        • 7.2.3.4. Murine
      • 7.2.4. Global Antibody Discovery by: Methods (Value)
        • 7.2.4.1. Phage Display
        • 7.2.4.2. Hybridoma
        • 7.2.4.3. Transgenic Animal
        • 7.2.4.4. Yeast Display
        • 7.2.4.5. Single Cell
      • 7.2.5. Global Antibody Discovery by: End User (Value)
        • 7.2.5.1. Pharmaceutical and Biotechnology Companies
        • 7.2.5.2. Research Laboratories
        • 7.2.5.3. Others
      • 7.2.6. Global Antibody Discovery Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Australia
          • 7.2.6.2.6. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Antibody Discovery: by Type(USD Million)
  • Table 2. Antibody Discovery Monoclonal Antibodies , by Region USD Million (2017-2022)
  • Table 3. Antibody Discovery Polyclonal Antibodies , by Region USD Million (2017-2022)
  • Table 4. Antibody Discovery Other Antibodies , by Region USD Million (2017-2022)
  • Table 5. Antibody Discovery: by Application(USD Million)
  • Table 6. Antibody Discovery Healthcare Industry , by Region USD Million (2017-2022)
  • Table 7. Antibody Discovery: by Nature(USD Million)
  • Table 8. Antibody Discovery Humanized , by Region USD Million (2017-2022)
  • Table 9. Antibody Discovery Human , by Region USD Million (2017-2022)
  • Table 10. Antibody Discovery Chimeric , by Region USD Million (2017-2022)
  • Table 11. Antibody Discovery Murine , by Region USD Million (2017-2022)
  • Table 12. Antibody Discovery: by Methods(USD Million)
  • Table 13. Antibody Discovery Phage Display , by Region USD Million (2017-2022)
  • Table 14. Antibody Discovery Hybridoma , by Region USD Million (2017-2022)
  • Table 15. Antibody Discovery Transgenic Animal , by Region USD Million (2017-2022)
  • Table 16. Antibody Discovery Yeast Display , by Region USD Million (2017-2022)
  • Table 17. Antibody Discovery Single Cell , by Region USD Million (2017-2022)
  • Table 18. Antibody Discovery: by End User(USD Million)
  • Table 19. Antibody Discovery Pharmaceutical and Biotechnology Companies , by Region USD Million (2017-2022)
  • Table 20. Antibody Discovery Research Laboratories , by Region USD Million (2017-2022)
  • Table 21. Antibody Discovery Others , by Region USD Million (2017-2022)
  • Table 22. South America Antibody Discovery, by Country USD Million (2017-2022)
  • Table 23. South America Antibody Discovery, by Type USD Million (2017-2022)
  • Table 24. South America Antibody Discovery, by Application USD Million (2017-2022)
  • Table 25. South America Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 26. South America Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 27. South America Antibody Discovery, by End User USD Million (2017-2022)
  • Table 28. Brazil Antibody Discovery, by Type USD Million (2017-2022)
  • Table 29. Brazil Antibody Discovery, by Application USD Million (2017-2022)
  • Table 30. Brazil Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 31. Brazil Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 32. Brazil Antibody Discovery, by End User USD Million (2017-2022)
  • Table 33. Argentina Antibody Discovery, by Type USD Million (2017-2022)
  • Table 34. Argentina Antibody Discovery, by Application USD Million (2017-2022)
  • Table 35. Argentina Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 36. Argentina Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 37. Argentina Antibody Discovery, by End User USD Million (2017-2022)
  • Table 38. Rest of South America Antibody Discovery, by Type USD Million (2017-2022)
  • Table 39. Rest of South America Antibody Discovery, by Application USD Million (2017-2022)
  • Table 40. Rest of South America Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 41. Rest of South America Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 42. Rest of South America Antibody Discovery, by End User USD Million (2017-2022)
  • Table 43. Asia Pacific Antibody Discovery, by Country USD Million (2017-2022)
  • Table 44. Asia Pacific Antibody Discovery, by Type USD Million (2017-2022)
  • Table 45. Asia Pacific Antibody Discovery, by Application USD Million (2017-2022)
  • Table 46. Asia Pacific Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 47. Asia Pacific Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 48. Asia Pacific Antibody Discovery, by End User USD Million (2017-2022)
  • Table 49. China Antibody Discovery, by Type USD Million (2017-2022)
  • Table 50. China Antibody Discovery, by Application USD Million (2017-2022)
  • Table 51. China Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 52. China Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 53. China Antibody Discovery, by End User USD Million (2017-2022)
  • Table 54. Japan Antibody Discovery, by Type USD Million (2017-2022)
  • Table 55. Japan Antibody Discovery, by Application USD Million (2017-2022)
  • Table 56. Japan Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 57. Japan Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 58. Japan Antibody Discovery, by End User USD Million (2017-2022)
  • Table 59. India Antibody Discovery, by Type USD Million (2017-2022)
  • Table 60. India Antibody Discovery, by Application USD Million (2017-2022)
  • Table 61. India Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 62. India Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 63. India Antibody Discovery, by End User USD Million (2017-2022)
  • Table 64. South Korea Antibody Discovery, by Type USD Million (2017-2022)
  • Table 65. South Korea Antibody Discovery, by Application USD Million (2017-2022)
  • Table 66. South Korea Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 67. South Korea Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 68. South Korea Antibody Discovery, by End User USD Million (2017-2022)
  • Table 69. Australia Antibody Discovery, by Type USD Million (2017-2022)
  • Table 70. Australia Antibody Discovery, by Application USD Million (2017-2022)
  • Table 71. Australia Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 72. Australia Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 73. Australia Antibody Discovery, by End User USD Million (2017-2022)
  • Table 74. Rest of Asia-Pacific Antibody Discovery, by Type USD Million (2017-2022)
  • Table 75. Rest of Asia-Pacific Antibody Discovery, by Application USD Million (2017-2022)
  • Table 76. Rest of Asia-Pacific Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 77. Rest of Asia-Pacific Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 78. Rest of Asia-Pacific Antibody Discovery, by End User USD Million (2017-2022)
  • Table 79. Europe Antibody Discovery, by Country USD Million (2017-2022)
  • Table 80. Europe Antibody Discovery, by Type USD Million (2017-2022)
  • Table 81. Europe Antibody Discovery, by Application USD Million (2017-2022)
  • Table 82. Europe Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 83. Europe Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 84. Europe Antibody Discovery, by End User USD Million (2017-2022)
  • Table 85. Germany Antibody Discovery, by Type USD Million (2017-2022)
  • Table 86. Germany Antibody Discovery, by Application USD Million (2017-2022)
  • Table 87. Germany Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 88. Germany Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 89. Germany Antibody Discovery, by End User USD Million (2017-2022)
  • Table 90. France Antibody Discovery, by Type USD Million (2017-2022)
  • Table 91. France Antibody Discovery, by Application USD Million (2017-2022)
  • Table 92. France Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 93. France Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 94. France Antibody Discovery, by End User USD Million (2017-2022)
  • Table 95. Italy Antibody Discovery, by Type USD Million (2017-2022)
  • Table 96. Italy Antibody Discovery, by Application USD Million (2017-2022)
  • Table 97. Italy Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 98. Italy Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 99. Italy Antibody Discovery, by End User USD Million (2017-2022)
  • Table 100. United Kingdom Antibody Discovery, by Type USD Million (2017-2022)
  • Table 101. United Kingdom Antibody Discovery, by Application USD Million (2017-2022)
  • Table 102. United Kingdom Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 103. United Kingdom Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 104. United Kingdom Antibody Discovery, by End User USD Million (2017-2022)
  • Table 105. Netherlands Antibody Discovery, by Type USD Million (2017-2022)
  • Table 106. Netherlands Antibody Discovery, by Application USD Million (2017-2022)
  • Table 107. Netherlands Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 108. Netherlands Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 109. Netherlands Antibody Discovery, by End User USD Million (2017-2022)
  • Table 110. Rest of Europe Antibody Discovery, by Type USD Million (2017-2022)
  • Table 111. Rest of Europe Antibody Discovery, by Application USD Million (2017-2022)
  • Table 112. Rest of Europe Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 113. Rest of Europe Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 114. Rest of Europe Antibody Discovery, by End User USD Million (2017-2022)
  • Table 115. MEA Antibody Discovery, by Country USD Million (2017-2022)
  • Table 116. MEA Antibody Discovery, by Type USD Million (2017-2022)
  • Table 117. MEA Antibody Discovery, by Application USD Million (2017-2022)
  • Table 118. MEA Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 119. MEA Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 120. MEA Antibody Discovery, by End User USD Million (2017-2022)
  • Table 121. Middle East Antibody Discovery, by Type USD Million (2017-2022)
  • Table 122. Middle East Antibody Discovery, by Application USD Million (2017-2022)
  • Table 123. Middle East Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 124. Middle East Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 125. Middle East Antibody Discovery, by End User USD Million (2017-2022)
  • Table 126. Africa Antibody Discovery, by Type USD Million (2017-2022)
  • Table 127. Africa Antibody Discovery, by Application USD Million (2017-2022)
  • Table 128. Africa Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 129. Africa Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 130. Africa Antibody Discovery, by End User USD Million (2017-2022)
  • Table 131. North America Antibody Discovery, by Country USD Million (2017-2022)
  • Table 132. North America Antibody Discovery, by Type USD Million (2017-2022)
  • Table 133. North America Antibody Discovery, by Application USD Million (2017-2022)
  • Table 134. North America Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 135. North America Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 136. North America Antibody Discovery, by End User USD Million (2017-2022)
  • Table 137. United States Antibody Discovery, by Type USD Million (2017-2022)
  • Table 138. United States Antibody Discovery, by Application USD Million (2017-2022)
  • Table 139. United States Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 140. United States Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 141. United States Antibody Discovery, by End User USD Million (2017-2022)
  • Table 142. Canada Antibody Discovery, by Type USD Million (2017-2022)
  • Table 143. Canada Antibody Discovery, by Application USD Million (2017-2022)
  • Table 144. Canada Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 145. Canada Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 146. Canada Antibody Discovery, by End User USD Million (2017-2022)
  • Table 147. Mexico Antibody Discovery, by Type USD Million (2017-2022)
  • Table 148. Mexico Antibody Discovery, by Application USD Million (2017-2022)
  • Table 149. Mexico Antibody Discovery, by Nature USD Million (2017-2022)
  • Table 150. Mexico Antibody Discovery, by Methods USD Million (2017-2022)
  • Table 151. Mexico Antibody Discovery, by End User USD Million (2017-2022)
  • Table 152. Company Basic Information, Sales Area and Its Competitors
  • Table 153. Company Basic Information, Sales Area and Its Competitors
  • Table 154. Company Basic Information, Sales Area and Its Competitors
  • Table 155. Company Basic Information, Sales Area and Its Competitors
  • Table 156. Company Basic Information, Sales Area and Its Competitors
  • Table 157. Company Basic Information, Sales Area and Its Competitors
  • Table 158. Company Basic Information, Sales Area and Its Competitors
  • Table 159. Company Basic Information, Sales Area and Its Competitors
  • Table 160. Company Basic Information, Sales Area and Its Competitors
  • Table 161. Company Basic Information, Sales Area and Its Competitors
  • Table 162. Antibody Discovery: by Type(USD Million)
  • Table 163. Antibody Discovery Monoclonal Antibodies , by Region USD Million (2023-2028)
  • Table 164. Antibody Discovery Polyclonal Antibodies , by Region USD Million (2023-2028)
  • Table 165. Antibody Discovery Other Antibodies , by Region USD Million (2023-2028)
  • Table 166. Antibody Discovery: by Application(USD Million)
  • Table 167. Antibody Discovery Healthcare Industry , by Region USD Million (2023-2028)
  • Table 168. Antibody Discovery: by Nature(USD Million)
  • Table 169. Antibody Discovery Humanized , by Region USD Million (2023-2028)
  • Table 170. Antibody Discovery Human , by Region USD Million (2023-2028)
  • Table 171. Antibody Discovery Chimeric , by Region USD Million (2023-2028)
  • Table 172. Antibody Discovery Murine , by Region USD Million (2023-2028)
  • Table 173. Antibody Discovery: by Methods(USD Million)
  • Table 174. Antibody Discovery Phage Display , by Region USD Million (2023-2028)
  • Table 175. Antibody Discovery Hybridoma , by Region USD Million (2023-2028)
  • Table 176. Antibody Discovery Transgenic Animal , by Region USD Million (2023-2028)
  • Table 177. Antibody Discovery Yeast Display , by Region USD Million (2023-2028)
  • Table 178. Antibody Discovery Single Cell , by Region USD Million (2023-2028)
  • Table 179. Antibody Discovery: by End User(USD Million)
  • Table 180. Antibody Discovery Pharmaceutical and Biotechnology Companies , by Region USD Million (2023-2028)
  • Table 181. Antibody Discovery Research Laboratories , by Region USD Million (2023-2028)
  • Table 182. Antibody Discovery Others , by Region USD Million (2023-2028)
  • Table 183. South America Antibody Discovery, by Country USD Million (2023-2028)
  • Table 184. South America Antibody Discovery, by Type USD Million (2023-2028)
  • Table 185. South America Antibody Discovery, by Application USD Million (2023-2028)
  • Table 186. South America Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 187. South America Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 188. South America Antibody Discovery, by End User USD Million (2023-2028)
  • Table 189. Brazil Antibody Discovery, by Type USD Million (2023-2028)
  • Table 190. Brazil Antibody Discovery, by Application USD Million (2023-2028)
  • Table 191. Brazil Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 192. Brazil Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 193. Brazil Antibody Discovery, by End User USD Million (2023-2028)
  • Table 194. Argentina Antibody Discovery, by Type USD Million (2023-2028)
  • Table 195. Argentina Antibody Discovery, by Application USD Million (2023-2028)
  • Table 196. Argentina Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 197. Argentina Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 198. Argentina Antibody Discovery, by End User USD Million (2023-2028)
  • Table 199. Rest of South America Antibody Discovery, by Type USD Million (2023-2028)
  • Table 200. Rest of South America Antibody Discovery, by Application USD Million (2023-2028)
  • Table 201. Rest of South America Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 202. Rest of South America Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 203. Rest of South America Antibody Discovery, by End User USD Million (2023-2028)
  • Table 204. Asia Pacific Antibody Discovery, by Country USD Million (2023-2028)
  • Table 205. Asia Pacific Antibody Discovery, by Type USD Million (2023-2028)
  • Table 206. Asia Pacific Antibody Discovery, by Application USD Million (2023-2028)
  • Table 207. Asia Pacific Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 208. Asia Pacific Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 209. Asia Pacific Antibody Discovery, by End User USD Million (2023-2028)
  • Table 210. China Antibody Discovery, by Type USD Million (2023-2028)
  • Table 211. China Antibody Discovery, by Application USD Million (2023-2028)
  • Table 212. China Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 213. China Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 214. China Antibody Discovery, by End User USD Million (2023-2028)
  • Table 215. Japan Antibody Discovery, by Type USD Million (2023-2028)
  • Table 216. Japan Antibody Discovery, by Application USD Million (2023-2028)
  • Table 217. Japan Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 218. Japan Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 219. Japan Antibody Discovery, by End User USD Million (2023-2028)
  • Table 220. India Antibody Discovery, by Type USD Million (2023-2028)
  • Table 221. India Antibody Discovery, by Application USD Million (2023-2028)
  • Table 222. India Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 223. India Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 224. India Antibody Discovery, by End User USD Million (2023-2028)
  • Table 225. South Korea Antibody Discovery, by Type USD Million (2023-2028)
  • Table 226. South Korea Antibody Discovery, by Application USD Million (2023-2028)
  • Table 227. South Korea Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 228. South Korea Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 229. South Korea Antibody Discovery, by End User USD Million (2023-2028)
  • Table 230. Australia Antibody Discovery, by Type USD Million (2023-2028)
  • Table 231. Australia Antibody Discovery, by Application USD Million (2023-2028)
  • Table 232. Australia Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 233. Australia Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 234. Australia Antibody Discovery, by End User USD Million (2023-2028)
  • Table 235. Rest of Asia-Pacific Antibody Discovery, by Type USD Million (2023-2028)
  • Table 236. Rest of Asia-Pacific Antibody Discovery, by Application USD Million (2023-2028)
  • Table 237. Rest of Asia-Pacific Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 238. Rest of Asia-Pacific Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 239. Rest of Asia-Pacific Antibody Discovery, by End User USD Million (2023-2028)
  • Table 240. Europe Antibody Discovery, by Country USD Million (2023-2028)
  • Table 241. Europe Antibody Discovery, by Type USD Million (2023-2028)
  • Table 242. Europe Antibody Discovery, by Application USD Million (2023-2028)
  • Table 243. Europe Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 244. Europe Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 245. Europe Antibody Discovery, by End User USD Million (2023-2028)
  • Table 246. Germany Antibody Discovery, by Type USD Million (2023-2028)
  • Table 247. Germany Antibody Discovery, by Application USD Million (2023-2028)
  • Table 248. Germany Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 249. Germany Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 250. Germany Antibody Discovery, by End User USD Million (2023-2028)
  • Table 251. France Antibody Discovery, by Type USD Million (2023-2028)
  • Table 252. France Antibody Discovery, by Application USD Million (2023-2028)
  • Table 253. France Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 254. France Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 255. France Antibody Discovery, by End User USD Million (2023-2028)
  • Table 256. Italy Antibody Discovery, by Type USD Million (2023-2028)
  • Table 257. Italy Antibody Discovery, by Application USD Million (2023-2028)
  • Table 258. Italy Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 259. Italy Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 260. Italy Antibody Discovery, by End User USD Million (2023-2028)
  • Table 261. United Kingdom Antibody Discovery, by Type USD Million (2023-2028)
  • Table 262. United Kingdom Antibody Discovery, by Application USD Million (2023-2028)
  • Table 263. United Kingdom Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 264. United Kingdom Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 265. United Kingdom Antibody Discovery, by End User USD Million (2023-2028)
  • Table 266. Netherlands Antibody Discovery, by Type USD Million (2023-2028)
  • Table 267. Netherlands Antibody Discovery, by Application USD Million (2023-2028)
  • Table 268. Netherlands Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 269. Netherlands Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 270. Netherlands Antibody Discovery, by End User USD Million (2023-2028)
  • Table 271. Rest of Europe Antibody Discovery, by Type USD Million (2023-2028)
  • Table 272. Rest of Europe Antibody Discovery, by Application USD Million (2023-2028)
  • Table 273. Rest of Europe Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 274. Rest of Europe Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 275. Rest of Europe Antibody Discovery, by End User USD Million (2023-2028)
  • Table 276. MEA Antibody Discovery, by Country USD Million (2023-2028)
  • Table 277. MEA Antibody Discovery, by Type USD Million (2023-2028)
  • Table 278. MEA Antibody Discovery, by Application USD Million (2023-2028)
  • Table 279. MEA Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 280. MEA Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 281. MEA Antibody Discovery, by End User USD Million (2023-2028)
  • Table 282. Middle East Antibody Discovery, by Type USD Million (2023-2028)
  • Table 283. Middle East Antibody Discovery, by Application USD Million (2023-2028)
  • Table 284. Middle East Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 285. Middle East Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 286. Middle East Antibody Discovery, by End User USD Million (2023-2028)
  • Table 287. Africa Antibody Discovery, by Type USD Million (2023-2028)
  • Table 288. Africa Antibody Discovery, by Application USD Million (2023-2028)
  • Table 289. Africa Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 290. Africa Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 291. Africa Antibody Discovery, by End User USD Million (2023-2028)
  • Table 292. North America Antibody Discovery, by Country USD Million (2023-2028)
  • Table 293. North America Antibody Discovery, by Type USD Million (2023-2028)
  • Table 294. North America Antibody Discovery, by Application USD Million (2023-2028)
  • Table 295. North America Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 296. North America Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 297. North America Antibody Discovery, by End User USD Million (2023-2028)
  • Table 298. United States Antibody Discovery, by Type USD Million (2023-2028)
  • Table 299. United States Antibody Discovery, by Application USD Million (2023-2028)
  • Table 300. United States Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 301. United States Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 302. United States Antibody Discovery, by End User USD Million (2023-2028)
  • Table 303. Canada Antibody Discovery, by Type USD Million (2023-2028)
  • Table 304. Canada Antibody Discovery, by Application USD Million (2023-2028)
  • Table 305. Canada Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 306. Canada Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 307. Canada Antibody Discovery, by End User USD Million (2023-2028)
  • Table 308. Mexico Antibody Discovery, by Type USD Million (2023-2028)
  • Table 309. Mexico Antibody Discovery, by Application USD Million (2023-2028)
  • Table 310. Mexico Antibody Discovery, by Nature USD Million (2023-2028)
  • Table 311. Mexico Antibody Discovery, by Methods USD Million (2023-2028)
  • Table 312. Mexico Antibody Discovery, by End User USD Million (2023-2028)
  • Table 313. Research Programs/Design for This Report
  • Table 314. Key Data Information from Secondary Sources
  • Table 315. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Antibody Discovery: by Type USD Million (2017-2022)
  • Figure 5. Global Antibody Discovery: by Application USD Million (2017-2022)
  • Figure 6. Global Antibody Discovery: by Nature USD Million (2017-2022)
  • Figure 7. Global Antibody Discovery: by Methods USD Million (2017-2022)
  • Figure 8. Global Antibody Discovery: by End User USD Million (2017-2022)
  • Figure 9. South America Antibody Discovery Share (%), by Country
  • Figure 10. Asia Pacific Antibody Discovery Share (%), by Country
  • Figure 11. Europe Antibody Discovery Share (%), by Country
  • Figure 12. MEA Antibody Discovery Share (%), by Country
  • Figure 13. North America Antibody Discovery Share (%), by Country
  • Figure 14. Global Antibody Discovery share by Players 2022 (%)
  • Figure 15. Global Antibody Discovery share by Players (Top 3) 2022(%)
  • Figure 16. Global Antibody Discovery share by Players (Top 5) 2022(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Twist Bioscience Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 19. Twist Bioscience Corporation (United States) Revenue: by Geography 2022
  • Figure 20. Croda International Plc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 21. Croda International Plc. (United Kingdom) Revenue: by Geography 2022
  • Figure 22. BASF SE. (Germany) Revenue, Net Income and Gross profit
  • Figure 23. BASF SE. (Germany) Revenue: by Geography 2022
  • Figure 24. Bruker Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 25. Bruker Corporation (United States) Revenue: by Geography 2022
  • Figure 26. Alcami Corporation, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Alcami Corporation, Inc. (United States) Revenue: by Geography 2022
  • Figure 28. BioDuro-Sundia. (China) Revenue, Net Income and Gross profit
  • Figure 29. BioDuro-Sundia. (China) Revenue: by Geography 2022
  • Figure 30. PharmaCircle LLC. (United States) Revenue, Net Income and Gross profit
  • Figure 31. PharmaCircle LLC. (United States) Revenue: by Geography 2022
  • Figure 32. Frontage Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Frontage Laboratories, Inc. (United States) Revenue: by Geography 2022
  • Figure 34. Eurofins DiscoverX Products, LLC. (French) Revenue, Net Income and Gross profit
  • Figure 35. Eurofins DiscoverX Products, LLC. (French) Revenue: by Geography 2022
  • Figure 36. Cambrex Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 37. Cambrex Corporation (United States) Revenue: by Geography 2022
  • Figure 38. Global Antibody Discovery: by Type USD Million (2023-2028)
  • Figure 39. Global Antibody Discovery: by Application USD Million (2023-2028)
  • Figure 40. Global Antibody Discovery: by Nature USD Million (2023-2028)
  • Figure 41. Global Antibody Discovery: by Methods USD Million (2023-2028)
  • Figure 42. Global Antibody Discovery: by End User USD Million (2023-2028)
  • Figure 43. South America Antibody Discovery Share (%), by Country
  • Figure 44. Asia Pacific Antibody Discovery Share (%), by Country
  • Figure 45. Europe Antibody Discovery Share (%), by Country
  • Figure 46. MEA Antibody Discovery Share (%), by Country
  • Figure 47. North America Antibody Discovery Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Twist Bioscience Corporation (United States)
  • Croda International Plc. (United Kingdom)
  • BASF SE. (Germany)
  • Bruker Corporation (United States)
  • Alcami Corporation, Inc. (United States)
  • BioDuro-Sundia. (China)
  • PharmaCircle LLC. (United States)
  • Frontage Laboratories, Inc. (United States)
  • Eurofins DiscoverX Products, LLC. (French)
  • Cambrex Corporation (United States)
Additional players considered in the study are as follows:
Abcentra (United States) , AbCheck (Czechia) , Abeome (United States) , Others
Select User Access Type

Key Highlights of Report


Apr 2023 248 Pages 97 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Antibody Discovery Market Quantitative research analysis
Global Antibody Discovery Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global Antibody Discovery Market are Twist Bioscience Corporation (United States), Croda International Plc. (United Kingdom), BASF SE. (Germany), Bruker Corporation (United States), Alcami Corporation, Inc. (United States), BioDuro-Sundia. (China), PharmaCircle LLC. (United States), Frontage Laboratories, Inc. (United States), Eurofins DiscoverX Products, LLC. (French) and Cambrex Corporation (United States) etc.
Healthcare Industry segment in Global market to hold robust market share owing to "Proteomics and Genomics Research is on the Rise ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Antibody Discovery market throughout the forecasted period.

Know More About Global Antibody Discovery Market Report?

Have a Query? Click Here

Other Related Reports

Shoulder Impingement Syndrome Comprehensive Study by Type (Structural, Functional), Shoulder Impingement Syndrome (Anterior Acromial Impingement, Posterosuperior Glenoid Rim Impingement, Subcoracoid ...
$ 4000
In-vivo Contract Research Organization Comprehensive Study by Services (Clinical Trials, Research Support), Therapeutic Areas (Autoimmune, Pain Management, Oncology, Nephrology, Diabetes, Cardiovascu...
$ 3800
Heart Transplant Comprehensive Study by Demographics (Gender, -Male, -Female, -Unisex, Age, -0-10 Years, -11-29 Years, -30-49 Years, -50-69 Years, Others), End Users (Hospitals, Cardiac Institute, Ot...
$ 3800
Systemic Psoriasis Therapeutic Comprehensive Study by Type (Plaque Psoriasis, Psoriatic Arthritis, Others), Route of Administration (Oral, Parenteral/Systemic, Topical), Distribution Channel (Direct,...
$ 3800
Systemic Lupus Erythematosus Treatment Comprehensive Study by Type (Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Antimalarial Drugs, Corticosteroids, Immunosuppressants, Biologics, Others), End use...
$ 3800
Human Papillomavirus Therapeutics Comprehensive Study by Route of Administration (Parenteral, Topical), Vaccine Type (Peptide-based Vaccines, Protein-based Vaccines, Viral-vectored vaccines, Bacteria...
$ 3800